EW vs SYM · P/E 47, rev $1.39B vs rev $2.25B
Edwards Lifesciences Corp (EW) versus Symbotic Inc (SYM) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Symbotic Inc (SYM) is a specialty industrial machinery company listed on NASDAQ.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported SYM revenue for 2025-09-27 was $2.25B. Net income was -$91.0M. Revenue was up 298.0% from 2024-09-28 to 2025-09-27. SYM currently screens at market cap $24.25B.
EW currently screens at market cap $49.91B and trailing P/E 46.9. SYM currently screens at market cap $24.25B.
Not investment advice. Open the EW and SYM stock pages for the full models.
Not investment advice.